NovoCure Ltd Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 19.25 | 12,500 | 240,625 | 25,000 | |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 80.06 | 100 | 8,006 | 76,976 | 77.1 K to 77 K (-0.13 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 79.41 | 3,857 | 306,288 | 77,076 | 80.9 K to 77.1 K (-4.77 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 78.68 | 2,455 | 193,150 | 80,933 | 83.4 K to 80.9 K (-2.94 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 77.28 | 2,800 | 216,376 | 83,388 | 86.2 K to 83.4 K (-3.25 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 76.39 | 2,710 | 207,017 | 86,188 | 88.9 K to 86.2 K (-3.05 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 75.04 | 578 | 43,372 | 88,898 | 89.5 K to 88.9 K (-0.65 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 19.25 | 12,500 | 240,625 | 89,476 | 77 K to 89.5 K (+16.24 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 27.60 | 7,500 | 207,000 | 22,500 | |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 70.00 | 7,500 | 525,000 | 76,976 | 84.5 K to 77 K (-8.88 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 27.60 | 7,500 | 207,000 | 84,476 | 77 K to 84.5 K (+9.74 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 27.60 | 7,500 | 207,000 | 22,500 | |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 70.00 | 7,500 | 525,000 | 76,976 | 84.5 K to 77 K (-8.88 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 27.60 | 7,500 | 207,000 | 84,476 | 77 K to 84.5 K (+9.74 %) |
| Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 24,743 | |
| Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 64.83 | 5,000 | 324,155 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
| Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 27.81 | 764 | 21,248 | 76,976 | 76.2 K to 77 K (+1.00 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Grant | A | 27.81 | 696 | 19,357 | 53,900 | 53.2 K to 53.9 K (+1.31 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 27.81 | 454 | 12,627 | 87,179 | 86.7 K to 87.2 K (+0.52 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Grant | A | 27.81 | 471 | 13,099 | 258,782 | 258.3 K to 258.8 K (+0.18 %) |
| Jul 02 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 7.15 | 187,500 | 1,340,625 | 187,500 | |
| Jul 02 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 62.15 | 187,500 | 11,653,125 | 258,311 | 445.8 K to 258.3 K (-42.06 %) |
| Jul 02 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 7.15 | 187,500 | 1,340,625 | 445,811 | 258.3 K to 445.8 K (+72.59 %) |